Similarly, the dysregulated activation of the PI3K/Akt signalling pathway is commonly associated with the proliferative ability of tumour cells in cancer progression, and miR‐125b is also implicated in this signalling pathway (Figure 1). The gene discussed is PIK3CB; the disease is cancer.